MedPath

AG-GABAPENTIN

AG-GABAPENTIN

Dormant
DIN Number

02477920

Drug Class

Human

Market Date

Sep 28, 2018

Company
HC

angita pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02477920
AIG Number0125929003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF01 GABAPENTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

GABAPENTINActive
Strength: 300 MG
Monograph: GABAPENTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.